Founder of Aequus Pharmaceuticals, Inc., Northview Ventures, Inc. and Northview Ventures & Associates General Partnership, Douglas Glen Janzen is an entrepreneur and businessperson who has been at the head of 9 different companies and currently is Chairman, President & Chief Executive Officer for Aequus Pharmaceuticals, Inc., President, Chief Executive Officer & MD at Northview Ventures, Inc., Managing Director at Northview Ventures & Associates General Partnership and Chairman of Lexington Biosciences Holdings Corp.

He is also on the board of 9 other companies.

Mr. Janzen previously held the position of Chairman of AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc., Head of Research at Loewen, Ondaatje, McCutcheon Ltd., Analyst at Cormark Securities, Inc., President, Chief Executive Officer & Director at Correvio Pharma Corp. and President & Chief Business Officer at Bradmer Pharmaceuticals, Inc.

Douglas Glen Janzen received an undergraduate degree from the University of Saskatchewan and a graduate degree from the University of British Columbia.